---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-028072"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2026-06-10T16:47:29+00:00"
generated_at: "2026-06-10T16:48:07.585876+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bio Green Med Solution raises $794K via sale of 1.1M shares at $0.72 each

## Summary
- Sold 1,103,338 shares of common stock at $0.72 per share for gross proceeds of $794,403.
- Proceeds will be used for general corporate and operating purposes.
- Shares issued in reliance on Regulation S exemption; not registered under Securities Act.
- Company entered into Registration Rights Agreement to register shares for resale.
- Closing occurred on June 10, 2026.

## SEC filing metadata
- accession: 0001493152-26-028072
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2026-06-10T16:47:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000149315226028072/0001493152-26-028072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000149315226028072/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-028072
- JSON: https://secwatch.observer/filing/0001493152-26-028072.json
- Plain text: https://secwatch.observer/filing/0001493152-26-028072.txt

## Key facts
- Equity Issuances
  Bio Green Med Solution, Inc. issued 1,103,338 shares of Common Stock of common stock to foreign accredited investors for $0.72 per share for aggregate gross proceeds of $794,403.
  - Security: common stock
  - Shares: 1,103,338 shares of Common Stock
  - Purchaser: foreign accredited investors
  - Consideration: $0.72 per share for aggregate gross proceeds of $794,403
  source text: an aggregate of 1,103,338 shares of Common Stock, par value $0.001 (the “Shares”) of the Company at a purchase price of $0.72 per share for aggregate gross proceeds of $794,403
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000149315226028072/0001493152-26-028072-index.htm
- Material Agreements
  Bio Green Med Solution, Inc. entered into Purchase Agreement with certain foreign accredited investors valued at aggregate gross proceeds of $794,403 (effective 2025-06-10).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain foreign accredited investors
  - Value: aggregate gross proceeds of $794,403
  - Effective: 2025-06-10
  source text: On June 10, 2025, Bio Green Med Solution, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain foreign accredited investors (the “Investors”), pursuant to which the Investors agreed to purchase from the Company an aggregate of 1,103,338 shares of Common Stock, par value $0.001 (the “Shares”) of the Company at a purchase price of $0.72 per share for aggregate gross proceeds of $794,403, subject to the terms and conditions of the Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000149315226028072/0001493152-26-028072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.